Journey Medical Corporation et al v. Teva Pharmaceuticals, Inc. et al
| Journey Medical Corporation and Rose U, LLC |
| Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. |
| 1:2022cv00288 |
| March 4, 2022 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 25, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 16 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries, Ltd. for Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc.. (Brauerman, Stephen) |
| Filing 15 ANSWER to #1 Complaint, Affirmative Defenses, COUNTERCLAIM against Journey Medical Corporation, Rose U, LLC by Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) |
| Filing 14 NOTICE of Withdrawal of Angela C. Whitesell as Counsel by Journey Medical Corporation, Rose U, LLC (Whitesell, Angela) |
Filing 13
SO ORDERED, re #12 Stipulation of Dismissal of Teva Pharmaceutical Industries Ltd., filed by Journey Medical Corporation, Rose U, LLC. Party Teva Pharmaceutical Industries Ltd. terminated. Attorney Ronald P. Golden, III terminated. Signed by Judge Colm F. Connolly on 3/31/2022. (kmd)
|
| Filing 12 STIPULATION of Dismissal of Teva Pharmaceutical Industries Ltd. by Journey Medical Corporation, Rose U, LLC. (Joyce, Alexandra) |
|
SO ORDERED, re #11 STIPULATION TO EXTEND TIME for Teva Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc. to Answer, Move, or Otherwise Respond to the Complaint to April 25, 2022, filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc. Reset Answer Deadlines: Teva Pharmaceuticals USA, Inc. answer due 4/25/2022; Teva Pharmaceuticals, Inc. answer due 4/25/2022. Ordered by Judge Colm F. Connolly on 3/23/2022. (kmd)
|
| Filing 11 STIPULATION TO EXTEND TIME for Teva Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc. to Answer, Move, or Otherwise Respond to the Complaint to April 25, 2022 - filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc.. (Golden, Ronald) |
| Pro Hac Vice Attorney Alissa M. Wood, Bonnie Fletcher Price, Daniel J. Knauss, Deepa Kannappan, Douglas W. Cheek, Jonathan R. Davies, Priyamvada Arora, and Sanya Sukduang for Journey Medical Corporation and Rose U, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Sanya Sukduang, Jonathan R. Davies, Bonnie Fletcher Price, Douglas W. Cheek, Daniel J. Knauss, Priyamvada Arora, Deepa Kannapan, and Alissa M. Wood - filed by Journey Medical Corporation, Rose U, LLC. (Joyce, Alexandra) |
|
SO ORDERED, re #10 MOTION for Pro Hac Vice Appearance of Attorney Sanya Sukduang, Jonathan R. Davies, Bonnie Fletcher Price, Douglas W. Cheek, Daniel J. Knauss, Priyamvada Arora, Deepa Kannapan, and Alissa M. Wood, filed by Journey Medical Corporation, Rose U, LLC. Ordered by Judge Colm F. Connolly on 3/9/2022. (kmd)
|
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 9 SUMMONS Returned Executed by Journey Medical Corporation, Rose U, LLC. Teva Pharmaceuticals USA, Inc. served on 3/4/2022, answer due 3/25/2022. (Joyce, Alexandra) |
| Filing 8 SUMMONS Returned Executed by Journey Medical Corporation, Rose U, LLC. Teva Pharmaceuticals, Inc. served on 3/4/2022, answer due 3/25/2022. (Joyce, Alexandra) |
| Filing 7 Summons Issued as to Teva Pharmaceutical Industries Ltd. on 3/4/2022; Teva Pharmaceuticals USA, Inc. on 3/4/2022; Teva Pharmaceuticals, Inc. on 3/4/2022. (Attachments: #1 Summons Issued Teva Pharmaceuticals, Inc., #2 Summons Issued Teva Pharmaceuticals USA, Inc.)(mal) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Fortress Biotech, Inc. for Journey Medical Corporation. No Parents or Affiliates Listed filed for Rose U, LLC - filed by Journey Medical Corporation and Rose U, LLC. (mal) |
| Filing 5 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,052,267 ;10,543,192 ;10,548,875. (mal) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,618,160 ;8,859,610 ;9,259,414 ;9,744,105 ;10,004,717. (mal) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 02/08/2022. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: No earlier than 8/8/2024. (mal) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Filing 1 COMPLAINT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3816972.) - filed by Journey Medical Corporation and Rose U, LLC. (Attachments: #1 Exhibit A-H, #2 Civil Cover Sheet)(mal) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
